Results 71 to 80 of about 5,602,030 (205)
Nationwide Study of Breast Cancer Risk Factors in Latinas [PDF]
Breast cancer is the most common cancer among American women. Any woman can be affected by breast cancer, with risk for the disease increasing with age. Risk for breast cancer is also exacerbated in women who have certain genetic alterations.
Julie Sawitzke +3 more
core +3 more sources
Lobar or sublobar resection for early-stage second primary lung cancer ≤ 3 cm in size: a SEER population-based study. [PDF]
Zhao K +9 more
europepmc +1 more source
Age-related differences in exercise and quality of life among breast cancer survivors [PDF]
Purpose: Physical activity has become a focus of cancer recovery research as it has the potential to reduce treatment-related burden and optimize health-related quality of life (HRQoL).
Arndt +34 more
core +2 more sources
Increased prevalence of precancerous changes in relatives of gastric cancer patients: critical role of H. pylori [PDF]
Background & Aims:Helicobacter pylori is believed to predispose to gastric cancer by inducing gastric atrophy and hypochlorhydria. First-degree relatives of patients with gastric cancer have an increased risk of developing gastric cancer.
El–Nujumi, Adil +8 more
core +1 more source
Background and Purpose: This study aimed to evaluate the impact of intrafractional diaphragm motion (IFDM) on dose accuracy in stereotactic body radiation therapy (SBRT) for lower thoracic vertebrae.
Fumiyasu Matsubayashi +3 more
doaj +1 more source
Pulmonary cryptococcosis mimicking lung cancer: 3 case report. [PDF]
Xin Z +5 more
europepmc +1 more source
J. Michael Smith, MD +7 more
doaj +1 more source
Background: The most recommended treatment for stage IV EGFR-positive lung cancer is osimertinib monotherapy. The dosage of osimertinib is fixed at 80 mg/day regardless of body surface area (BSA), however some patients withdraw or reduce the dosage due ...
Saki Tanaka +15 more
doaj +1 more source
P45. SURGICAL MANAGEMENT AND LONG-TERM OUTCOMES OF BIA-ALCL: A MULTI-DISCIPLINARY APPROACH
Joshua Vorstenbosch, MD, PhD +5 more
doaj +1 more source

